A phase II study result showed that administering a high dose of survodutide, up to 1.8 mg twice weekly, resulted in over 50% of T2D participants achieving more than 5% body weight reduction, and over 25% experiencing a weight loss exceeding 10% [111]
Based on its ability to cross the BBB, N-acetylcysteine amide (NACA) has been evaluated for its neuroprotective effect using cell lines and animal models of neurological diseases/disorders
Our results shed light on the acute cellular response to TBI and provide a means to locally deliver therapeutic compounds to the site of injury
Neutralizar posibles contaminantes del feto durante el embarazo
Reported Research Benefits Primarily investigated for improving skin regeneration, enhancing collagen and elastin synthesis, promoting wound healing, reducing scars and wrinkles, stimulating hair follicle growth, and modulating inflammation and oxidative stress in preclinical dermatological and regenerative medicine research